CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Montelukast for Patients with Rhinitis or Chronic Urticaria: Clinical Effectiveness

Last updated: July 14, 2020
Project Number: RA1126-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical effectiveness of montelukast for patients with allergic or chronic rhinitis or chronic idiopathic urticaria?

Key Message

Six systematic reviews (three with meta-analyses and two with network meta-analyses) and twenty-two randomized controlled trials were identified regarding the clinical effectiveness of montelukast for patients with allergic or chronic rhinitis or chronic idiopathic urticaria.